Martin Sophie, Tesse Angela, Hugel Bénédicte, Martínez M Carmen, Morel Olivier, Freyssinet Jean-Marie, Andriantsitohaina Ramaroson
Pharmacologie et Physico-Chimie des Interactions Cellulaires et Moléculaires, UMR CNRS 7034, Faculté de Pharmacie, Illkirch, France.
Circulation. 2004 Apr 6;109(13):1653-9. doi: 10.1161/01.CIR.0000124065.31211.6E. Epub 2004 Mar 15.
Microparticles (MPs) are membrane vesicles with procoagulant and proinflammatory properties released during cell activation. The present study was designed to dissect the effects evoked by T lymphocyte-derived MPs on vascular function.
MPs were produced by treatment of the human lymphoid CEM T cell line with actinomycin D or phytohemagglutinin. Incubation of mouse aortic rings with 30 nmol/L MPs resulted in a time-dependent impairment of acetylcholine-induced relaxation of precontracted vessels, with a maximal reduction after 24 hours. MPs also impaired shear stress-induced dilatation of mouse small mesenteric arteries by affecting the nitric oxide (NO) and prostacyclin but not the endothelium-derived hyperpolarizing factor components of the response. However, neither alteration of calcium signaling in response to agonists nor reduction of cyclooxygenase-1 expression accounted for the impairment of the NO and prostacyclin components of the endothelial response. The effect of MPs was rather because of a decrease in expression of endothelial NO synthase and an overexpression of caveolin-1. Furthermore, lymphocyte-derived MPs from diabetic patients or in vivo circulating MPs from either diabetic or HIV-infected patients reduced endothelial NO synthase expression. Finally, the effects of MPs on endothelial cells were not driven through CD11a/CD18 adhesion molecules or the Fas/FasL pathway.
MPs from T cells induce endothelial dysfunction in both conductance and resistance arteries by alteration of NO and prostacyclin pathways. MPs regulate protein expression for endothelial NO synthase and caveolin-1. These data contribute to a better understanding of the deleterious effects of enhanced circulating MPs observed in disorders with cardiovascular or immune complications.
微粒(MPs)是细胞活化过程中释放的具有促凝血和促炎特性的膜泡。本研究旨在剖析T淋巴细胞衍生的微粒对血管功能的影响。
通过用放线菌素D或植物血凝素处理人淋巴样CEM T细胞系来产生微粒。用30 nmol/L微粒孵育小鼠主动脉环会导致乙酰胆碱诱导的预收缩血管舒张出现时间依赖性损伤,24小时后损伤最大。微粒还通过影响一氧化氮(NO)和前列环素而损害小鼠小肠系膜动脉的剪切应力诱导的扩张,但不影响反应中的内皮衍生超极化因子成分。然而,激动剂刺激后钙信号的改变或环氧合酶-1表达的降低均不能解释内皮反应中NO和前列环素成分的损伤。微粒的作用相当于是由于内皮型一氧化氮合酶表达的降低和小窝蛋白-1的过表达。此外,糖尿病患者的淋巴细胞衍生微粒或糖尿病或HIV感染患者的体内循环微粒会降低内皮型一氧化氮合酶的表达。最后,微粒对内皮细胞的作用不是通过CD11a/CD18黏附分子或Fas/FasL途径介导的。
T细胞来源的微粒通过改变NO和前列环素途径诱导传导动脉和阻力动脉的内皮功能障碍。微粒调节内皮型一氧化氮合酶和小窝蛋白-1的蛋白表达。这些数据有助于更好地理解在心血管或免疫并发症疾病中观察到的循环微粒增加的有害影响。